Published in Pharma Investments, Ventures and Law Weekly, March 5th, 2006
Net sales for the second quarter were $69.5 million, compared to $76.7 million in the second quarter of fiscal year 2005. This decline reflects the previously disclosed decrease in sales of two active pharmaceutical ingredients (APIs) due to intense competition. Sales of those two products in the second quarter of fiscal year 2006 were $1.3 million, compared with $6.6 million in the second quarter of fiscal year 2005, a decrease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.